Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05198323 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT

Name: A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT — clinical trial record (NCT05198323)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 2

SponsorLumosa Therapeutics Co., Ltd.

Started2022-08-11

View on ClinicalTrials.gov ↗

A phase IIb clinical study to evaluate the safety and efficacy of single or multiple doses of LT3001 drug product in subjects with acute ischemic stroke (AIS) undergoing endovascular thrombectomy (EVT).

Amendment history 3 changes detected by DataLookout

2026-09-01

Enrollment closed, study ongoing

2026-09-01

Primary completion pushed: 2026-03-31 → 2026-12-31

2026-09-01

Completion pushed: 2026-03-31 → 2026-12-31

Trial Details

NCT Number	NCT05198323
Lead Sponsor	Lumosa Therapeutics Co., Ltd.
Conditions	Acute Ischemic Stroke
Enrollment	66 participants
Start Date	2022-08-11
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-31